Last updated: July 25, 2019
Sponsor: Beijing Neurosurgical Institute
Overall Status: Active - Recruiting
Phase
N/A
Condition
Germ Cell Tumors
Testicular Cancer
Treatment
N/AClinical Study ID
NCT03771625
2018-GEMF-1073
Ages > 3 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
age ≥3 years;
no history of brain radiotherapy;
no other known cause of movement and cognitive impairment;
no contraindications to the magnetic resonance imaging (MRI) scan;
Exclusion
Exclusion Criteria:
patients can not tolerate MR scan;
head motion is greater than 3 mm during functional MRI scanning.
Study Design
Total Participants: 30
Study Start date:
June 01, 2019
Estimated Completion Date:
November 01, 2021
Study Description
Connect with a study center
Beijing Tiantan Hospital
Beijing, 100071
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.